COST EFFECTIVE FORMULATION DEVELOPMENT OF ROSUVASTATIN IN COMPARED TO INNOVATOR BRAND & EVALUATION OF INTERCHANGEABILITY VIA IN-VITRO BIO-EQUIVALENCE STUDY

Journal Title: World Journal of Pharmaceutical Research - Year 2017, Vol 6, Issue 11

Abstract

Generic Rosuvastatin formulation has been developed which is comparatively cost-effective as well as bio-similar in efficacy in compared with the Brand drug Crestor (Rosuvastatin). Research shows that overpriced medicines causes huge national burden and health care expenses has gone out of control. A Study results shows that millions of adults patients skip over medications to buy due to their high cost (Robin A. Cohen, Maria A. Villarroel, NCSH Researchers. 2013).[1] Research also found that patients are used to save money on drugs costs and they asked doctors for lower-cost medications, buying prescription drugs from other countries and using alternative therapies. So, high drugs costs problems can be handled by development of cost-effective generic drugs with same therapeutic efficacy or bio-similar to brand name drugs. According to US. FDA - a generic medicine give the identical clinical benefit and works in the same way like other brand-name version drugs. This standard applies to all FDA-approved generic medicines in safety, dosage form, strength, quality, route of administration, and intended use”(US FDA 2017).[2] So, with the main focusing of cost-defective formulation development, we have tried to evaluate the overall quality of developed drugs from the points of - dosage form, therapeutic efficacy, strength, safety, route of administration, performance quality, characteristics and intended use. We have conducted an In-Vitro Bio-Equivalence Study to establish the bio-similarity of Generic Rosuvastatin and we have achieved similar results like Brand name Rosuvastatin- Crestor. New developed Generic Rosuvastatin tablets found therapeutically bio-equivalent as the Brand name innovator and more cost-effective than brand drug.

Authors and Affiliations

Farzana Hasin

Keywords

Related Articles

A REVIEW ON AROMA PROFILE OF CINNAMOMUM SPECIES IN NORTH AND NORTH EAST INDIA

Cinnamomum genus belonging to the family Lauraceace comprises of evergreen trees and shrubs. Over 250 species of Cinnamomum have been reported all over the world which are distributed in tropical and subtropical regions...

DIAGNOSTIC METHOD OF CHRONIC MERCURY TOXICITY AND ITS AYURVEDIC MANAGEMENT

Long term hazards due to prolong persistent continuous exposure of mercury causes chronic cumulative toxicity in human beings. Heavy industrialization, gold mining, utilization of fishes as a food containing methyl mercu...

IN INTENSİVE CARE UNİT COMPARİNG OF “MALNUTRİTİON UNİVERSAL SCREENİNG TOOL” (MUST) AND “NUTRİTİONAL RİSK SCREENİNG” (NRS-2002) TESTS İN TERMS OF PROGNOSTİC ASPECT

250 patients aged 18 and older in Pamukkale University Medical Faculty Hospital Anesthesiology and Reanimation Department Intensive Care Unit(ICU), between April 2014 and November 2016 were enrolled to the study. In ICU...

HOLISTIC APPROACH OF AYURVEDA IN GERIATRICS: REVIEW ARTICLE

In present era medical science deals exclusively with the problem of ageing and diseases occur due to ageing. Geriatrics is emerging as a main challenging specialty because of ever growing population of aged people all o...

COMPARISON STUDY BETWEEN INDEPENDENT COMPONENT ANALYSIS AND PRINCIPLE COMPONENT ANALYSIS IN THE CONTEXT OF HIDDEN SOURCE SEPARATION

The report presents comparative assessment of Blind Source Separation methods for instantaneous mixtures. The study highlights the underlying principles of Principal Component Analysis (PCA) and Independent Component Ana...

Download PDF file
  • EP ID EP674247
  • DOI -
  • Views 260
  • Downloads 0

How To Cite

Farzana Hasin (2017). COST EFFECTIVE FORMULATION DEVELOPMENT OF ROSUVASTATIN IN COMPARED TO INNOVATOR BRAND & EVALUATION OF INTERCHANGEABILITY VIA IN-VITRO BIO-EQUIVALENCE STUDY. World Journal of Pharmaceutical Research, 6(11), 72-86. https://europub.co.uk/articles/-A-674247